United Therapeutics UTHR announced that the FDA has issued a complete response letter to its new drug application (“NDA”) for its drug device combination therapy, Tyvaso Dry Powder Inhaler or ...

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2021/ PRNewswire/-- United Therapeutics Corporation announced today that it has launched commercial sales of the innovative Remunity ...

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Jan. 28, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that that the BREEZE study of Tyvaso DPI (inhaled ...

United Therapeutics, which is based in Maryland, said it is paying a premium of 170% over the “weighted” average price of Miromatrix shares dating to Oct. 27.

The stock price of United Therapeutics, a biotechnology company, has seen a rise of over 15% over the last twenty-one trading days, and it is up a solid 97% over the last twelve-month period. The ...